Advertisements



States spurn drug industry"s opioid-settlement offer

An $18 billion settlement offer from three major drug wholesalers to resolve litigation over the opioid crisis has fallen apart, after more than 20 state attorneys general rejected it in a letter earlier this week......»»

Category: topSource: moneycentralFeb 14th, 2020

The Wall Street Journal: State attorneys general reject $18 billion settlement with opioid wholesalers

An $18 billion offer from three major drug wholesalers aimed at settling litigation over their alleged role in the opioid crisis fell through, after more than 20 state attorneys general rejected it in a letter to the companies’ law firms this week......»»

Category: topSource: marketwatchFeb 14th, 2020

21 states rejected an $18 billion offer to settle opioid epidemic lawsuits, arguing it"s not enough

Justin Sullivan/Getty Images More than 20 states have rejected an offer from the pharmaceutical industry that would have paid some $18 billion over the course of 18 years to settle ongoing legislation drug companies' role in the opioi.....»»

Category: topSource: businessinsiderFeb 14th, 2020

States reject $18B opioid settlement offer from wholesalers, WSJ says

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 14th, 2020

The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar"s Opioid Drug

The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Jan. 13.) 0 read more.....»»

Category: blogSource: benzingaJan 14th, 2020

PreMarket Prep: Schizophrenic Drug Stocks, A Technical Play On Halliburton"s Q3 Report

Drug stocks were covered at the top of Monday's PreMarket Prep show with opioid litigation set to begin in an Ohio court.  read more.....»»

Category: blogSource: benzingaOct 21st, 2019

The Week Ahead In Biotech: Earnings Trickle In, While Glaxo, Melinta, Foamix And Eton Await FDA Verdict

Biotech stocks saw some strength last week. Positive clinical readouts, a couple of M&A deals and hopes of drug companies clinching a broader opioid settlement agreement worked in favor of the sector. read more.....»»

Category: blogSource: benzingaOct 20th, 2019

PreMarket Prep Recap: Stormy Outlook For Cloud Stocks, Opioid Makers Rally On Settlement Talks

On Wednesday's PreMarket Prep show, earnings reports and ratings changes took a backseat to the negative news for cloud stocks and the positive news for opioid-associated drug distributors. read more.....»»

Category: blogSource: benzingaOct 16th, 2019

McKesson, Cardinal Health, AmerisourceBergen stocks surge after WSJ report of $18 billion settlement talks

Shares of McKesson Corp. rallied 5.7% in midday trading Wednesday, enough to pace all of its larger-capitalization health care peers, after The Wall Street Journal reported that the drug distributor, and two others, were in talks.....»»

Category: topSource: marketwatchOct 16th, 2019

Drug distributors offer states $10B to settle opioid claims, Bloomberg reports

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 6th, 2019

Production of Opium-Based Drugs and Cocaine Is at an All-Time High

According to the 2018 World Drug Report, production jumped 65% between 2016 and 2017. As the United States faces its own opioid epidemic at home, a new report from the United Nations Office on Drugs and C.....»»

Category: europeSource: fortuneJun 27th, 2018

Generic drug stocks slammed by report of expanded price-fixing probe

Shares of generic drug makers fell sharply Monday, after a Washington Post report that an antitrust lawsuit brought by states over two drugs in 2016 has expanded into a major probe of alleged price-fixing across the industry......»»

Category: topSource: marketwatchDec 10th, 2018

Generic-drug stocks slammed by report of expanded price-fixing probe

Shares of generic drug makers fell sharply Monday, after a Washington Post report that an antitrust lawsuit brought by states over two drugs in 2016 has expanded into a major probe of alleged price-fixing across the industry......»»

Category: topSource: marketwatchDec 11th, 2018

Steven Cohen Renews His Interest in Verastem

Guru invests in restructuring cancer drug developerCheck out Steven Cohen Stock Picks » Download GuruFolio Report of Steven Cohen (Updated on 02/04/2020)Related Stocks: VSTM, AIMT, APTO, BCRX, BOLD, CBAY, CMRX, CTMX, EPZM, FATE,.....»»

Category: blogSource: gurufocusFeb 5th, 2020

The Daily Biotech Pulse: EyePoint In-Licenses Eye Disorder Drug, BioMarin CFO Quits, Rockwell Medical To Offer Shares

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 3.) 0 read more.....»»

Category: blogSource: benzingaFeb 4th, 2020

The Daily Biotech Pulse: EyePoint In-Licenses Eye Disorder Drug, BioMarin CFO Quits, Rockwell Medical To Offer Shares

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 3.) Acceleron Pharma Inc (NASDAQ: XLRN) Aptose Biosciences .....»»

Category: earningsSource: benzingaFeb 4th, 2020

Oil falls for third day amid growing concern over China virus

Oil prices fell to their lowest in seven weeks on Thursday on concerns that the spread of a newly identified respiratory virus from China may lower fuel demand at the same time a report showed oil inventories in the United States rose last week......»»

Category: topSource: reutersJan 22nd, 2020

The Daily Biotech Pulse: Nektar Withdraws Opioid Pain Drug NDA, Galapagos Takes Stake In Fibrocor, Integra Lifesciences Lowers Q4 Guidance

The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Jan. 14.) 0 read more.....»»

Category: blogSource: benzingaJan 15th, 2020

Wall Street dips from record in "Jason Bourne market"

U.S. stocks hit intra-day record highs on Tuesday before turning negative following a report that the United States would likely maintain tariffs on Chinese goods until after November's presidential election......»»

Category: topSource: reutersJan 14th, 2020

Oil falls 1% as focus shifts to high U.S. fuel stocks

Oil prices fell about 1% on Monday as Middle East tensions eased and investors turned their focus to lackluster seasonal demand following last week's bearish U.S. report showing a large fuel stockbuilds......»»

Category: topSource: reutersJan 13th, 2020